United Therapeutics

Read more
Martine Rothblatt's photo - Founder & CEO of United Therapeutics

Founder & CEO

Martine Rothblatt

CEO Approval Rating

67/100

Founded:

1996

Status:

PublicIndependent CompanyNASDAQUTHR

UNITED THERAPEUTICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Actelion is the top competitor of United Therapeutics. Actelion is headquartered in Allschwil, Basel-Country, and was founded in 1997. Actelion competes in the Pharmaceuticals field. Actelion generates 157% the revenue of United Therapeutics.

Gilead is perceived as one of United Therapeutics's biggest rivals. Gilead was founded in Foster City, California} in 1987. Like United Therapeutics, Gilead also operates in the Biotechnology industry. Compared to United Therapeutics, Gilead generates $24.1B more revenue.

Amgen is seen as one of United Therapeutics's top competitors. Amgen is a Public company that was founded in Thousand Oaks, California in 1980. Like United Therapeutics, Amgen also works within the Biotechnology industry. Amgen has 23,440 more employees vs. United Therapeutics.

United Therapeutics Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$1.5B

United Therapeutics's revenue is the ranked 19th among it's top 10 competitors. The top 10 competitors average 24.8B. Over the last four quarters, United Therapeutics's revenue has grown by 4.7%. Specifically, in Q1 2021's revenue was $379.1M; in Q4 2020, it was $384.9M; in Q3 2020, it was $380.1M; in Q2 2020, United Therapeutics's revenue was $362M.

United Therapeutics Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Priority Review Voucher

Dec 2020

Source »
$105M
-

United Therapeutics Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Jun 1999
$54M
-

United Therapeutics Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Celularity is a biotechnology company that develops cell and tissue regenerative therapies for cancer, chronic and degenerative diseases.
$250M
Feb 14, 2018
Series A
-

United Therapeutics News

United Therapeutics Press Releases

Social Media

United Therapeutics Headquarters

1040 Spring Street

Silver Spring, Maryland20910

301-608-9292

Driving Directions »

Trending Companies

United Therapeutics Summary

ABOUT

Overview

United Therapeutics focused on the development and commercialization of unique products. United Therapeutics was founded in 1996. United Therapeutics' headquarters is located in Silver Spring, Maryland, USA 20910. It has raised 54.0M in 1 round. The l...

CEO

United Therapeutics's Founder & CEO, Martine Rothblatt, currently has an approval rating of 67%. United Therapeutics's primary competitors are Actelion, Gilead & Amgen.

Frequently Asked Questions about United Therapeutics

  1. When was United Therapeutics founded?

    United Therapeutics was founded in 1996
  2. Who is United Therapeutics's CEO?

    United Therapeutics's CEO is Martine Rothblatt
  3. How much revenue does United Therapeutics generate?

    United Therapeutics generates $1.5B in revenue
  4. How much funding does United Therapeutics have?

    United Therapeutics has historically raised $54M in funding
  5. Where is United Therapeutics's headquarters?

    United Therapeutics's headquarters is in Silver Spring Maryland, USA
  1. How many employees does United Therapeutics have?

    United Therapeutics has 860 employees
  2. What sector does United Therapeutics operate in?

    United Therapeutics is in Biotechnology
  3. Who are United Therapeutics's competitors?

    United Therapeutics's top competitors are Actelion, Gilead, Amgen
  4. Who has United Therapeutics invested in?

    United Therapeutics's has invested in companies such as Celularity